Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 6247-6251, November 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toguchida, J.
Right arrow Articles by Yamamuro, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toguchida, J.
Right arrow Articles by Yamamuro, T.

Assignment of Common Allele Loss in Osteosarcoma to the Subregion 17p131

Junya Toguchida2, Kanji Ishizaki3, Yusuke Nakamura, Masao S. Sasaki, Mituo Ikenaga, Mitsuo Kato, Masayuki Sugimoto, Yoshihiko Kotoura and Takao Yamamuro

Radiation Biology Center [J. T., K. I., M. S. S., M. I., M. K.] and Department of Orthopaedic Surgery, Faculty of Medicine [J. T., M. S., Y. K., T. Y.], Kyoto University, Yoshida-konoecho, Sakyo-ku, Kyoto 606, Japan; and Howard Hughes Medical Institute and Department of Human Genetics, University of Utah Medical Center, Salt Lake City, Utah 84132 [Y. N.]

Human osteosarcomas frequently show loss of alleles on chromosome 17 as well as those on chromosome 13 that harbors the retinoblastoma gene, indicating concerted operation of another tumor-suppressing gene on chromosome 17. To assign the affected gene to a defined region of chromosome 17, we performed mitotic recombination/deletion mapping by the use of 10 polymorphic loci on chromosome 17. Of 37 tumors studied, 28 (75.7%) showed loss of heterozygosity on chromosome 17. The affected regions varied among tumors, ranging in extent from a whole chromosome to a distal segment of the short arm. However, allele loss in one region, notably in 17p13 between D17S1 and D17S30, was common to all 28 tumors, suggesting the presence of a tumor-suppressing gene in this defined region.

1 Supported in part by grants from the Ministry of Education, Science, and Culture, and the Ministry of Health and Welfare, Japan.

2 Present address: Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 243 Charles Street, Boston, MA 02114.

3 To whom requests for reprints should be addressed.

Received 4/24/89. Revised 8/11/89. Accepted 8/18/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.